Table 3.
Concentrations (pg/mL) of the detected inflammatory molecules by ELISA (n = 80).
| Study group | Concentration | GLM∗∗ | |||
|---|---|---|---|---|---|
| Mean (SE)∗ | Coefficient | SE | 95% CI | P value | |
| MMP-8 | |||||
| DM + CP | 1256.27 (166.65) | 0.22 | 0.28 | (−0.32, 0.77) | 0.42 |
| CP | 1305.30 (193.85) | 0.34 | 0.27 | (−0.19, 0.87) | 0.21 |
| DM | 923.35 (194.74) | Reference group | |||
| MMP-9 | |||||
| DM + CP | 16188.39 (1303.30) | 0.24 | 0.16 | (−0.08, 0.56) | 0.14 |
| CP | 14147.76 (1274.33) | 0.15 | 0.17 | (−0.17, 0.48) | 0.36 |
| DM | 11378.75 (1401.43) | Reference group | |||
| OPG | |||||
| DM + CP | 33.51 (7.11) | 0.43 | 0.57 | (−0.69, 1.55) | 0.45 |
| CP | 39.91 (10.02) | 0.72 | 0.55 | (−0.36, 1.79) | 0.12 |
| DM | 23.53 (4.26) | Reference group | |||
∗Kruskal-Wallis test.
∗∗Generalized linear models with Gaussian family and log function adjusting for age, gender, smoking status, and ethnicity.